1. Home
  2. EPOW vs SCYX Comparison

EPOW vs SCYX Comparison

Compare EPOW & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPOW
  • SCYX
  • Stock Information
  • Founded
  • EPOW 2014
  • SCYX 1999
  • Country
  • EPOW China
  • SCYX United States
  • Employees
  • EPOW N/A
  • SCYX N/A
  • Industry
  • EPOW Business Services
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EPOW Consumer Discretionary
  • SCYX Health Care
  • Exchange
  • EPOW Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • EPOW 24.5M
  • SCYX 28.5M
  • IPO Year
  • EPOW 2021
  • SCYX 2014
  • Fundamental
  • Price
  • EPOW $0.92
  • SCYX $0.73
  • Analyst Decision
  • EPOW
  • SCYX
  • Analyst Count
  • EPOW 0
  • SCYX 0
  • Target Price
  • EPOW N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • EPOW 17.5K
  • SCYX 197.3K
  • Earning Date
  • EPOW 08-05-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • EPOW N/A
  • SCYX N/A
  • EPS Growth
  • EPOW N/A
  • SCYX N/A
  • EPS
  • EPOW N/A
  • SCYX N/A
  • Revenue
  • EPOW $64,997,741.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • EPOW N/A
  • SCYX $410.22
  • Revenue Next Year
  • EPOW N/A
  • SCYX $248.83
  • P/E Ratio
  • EPOW N/A
  • SCYX N/A
  • Revenue Growth
  • EPOW 44.28
  • SCYX N/A
  • 52 Week Low
  • EPOW $0.55
  • SCYX $0.66
  • 52 Week High
  • EPOW $1.36
  • SCYX $2.21
  • Technical
  • Relative Strength Index (RSI)
  • EPOW 47.83
  • SCYX 46.63
  • Support Level
  • EPOW $0.87
  • SCYX $0.67
  • Resistance Level
  • EPOW $0.95
  • SCYX $0.83
  • Average True Range (ATR)
  • EPOW 0.05
  • SCYX 0.04
  • MACD
  • EPOW -0.00
  • SCYX 0.01
  • Stochastic Oscillator
  • EPOW 29.41
  • SCYX 37.56

About EPOW Sunrise New Energy Co. Ltd

Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: